ABCDEFGHIJKLMNOPQRSTUVWXYZAAAB
1
Workshop: Seizing Policy Opportunities for Life Extension and Overcoming Political Obstacles in 2026
Led by Gennady Stolyarov II, Chairman, United States Transhumanist Party
2
Presented at Vitalist Bay - Thursday, May 14, 2026
Policy OpportunitiesPolitical Obstacles
3
Expanded Right to TryARPA-H Funding for Vitalist-Aligned ProjectsExpedited FDA ApprovalsFree Economic Zones / Freedom CitiesPotential Pro-Longevity Programs in Other CountriesPartisan PolarizationCuts to NIH FundingAnti-Vaccine / Anti-Science SentimentsUnrelated Political Conflicts Stifling Longevity Research
4
Example 1:Montana Right to Try Act - SB 422 (2023) and SB 535 (2025)FRONT Program (Functional Repair of Neocortical Tissue), Jean HebertExpanded Access granted to daraxonrasib, anti-pancreatic-cancer drug, on May 1, 2026, 2 days after FDA received the application.Próspera / Infinita CityRussian $26 billion investment into "anti-aging vaccines" (really, a gene-therapy drug that would target the RAGE receptor)Example 1:Rise in left-wing opposition to transhumanism because of alleged association with Peter Thiel and Elon Musk (who have not self-identified as transhumanists)New NIH grants for both Alzheimer's Disease and aging research reduced by about halfDelays, Eligibility Restrictions to Public Access to mRNA and Novavax Vaccines in 2025Cuts to Harvard labs (David Sinclair, George Church) in 2025 due to Trump Adminsitration's dispute with Ivy League universities (though most funding recovered by October 2025)
5
Example 2:New Hampshire Expanded Right to Try Law (HB 701, 2025) - Propsed HB 1734, HB 1735 (2026)PROSPR Program (Proactive Solutions for Prolonging Resilience), Andrew Brack49 FDA-approved cell and gene therapies as of April 23, 2026Immortalis / NeoviaInitiatives in Javier Milei's Argentina?Example 2:Reflexive Democratic opposition to New Hampshire Right to Try LawsHundreds of cancer-related research grants were terminated, including research into a novel treatment for glioblastoma using nanoparticles by Eden Tanner at the University of Mississippi22 mRNA vaccine research projects cancelled and defunded in 2025, no new mRNA-based projects allowed be initiatedGeopolitical conflicts (e.g., tensions with Russia over Ukraine and with China over Taiwan) preventing meaningful collaboration and exchange of ideas and research findings
6
Example 3: Nevada Freedom to Try Medical Innovations Amendment (Potential 2026 Ballot Initiative)PRINT Program (Personalized Regenerative Immunocompetent Nanotechnology Tissue),
Ryan Spitler
FDA allowed the Investigational New Drug (IND) application of EVM14, an mRNA anti-cancer vaccine for non-small-cell lung cancer and head and neck cancer (March 2025), Phase I trials began in November 2025.Viva City / Frontier TowerChina's booming longevity industry, considered a national priority by the government, with the support of Xi JinpingExample 3: Democrats in the House of Representatives largely opposed the Federal Right to Try Act of 2017, which passed the House by a vote of 267 to 149 on the second try, with most Democrats opposed.National Instute of Aging cut funding for the Dog Aging Project in 2024. (The project has since been continued due to private funding.)Bans on in vitro / lab-grown meat in 8 States: Alabama, Florida, Indiana, Mississippi, Montana, Nebraska, South Dakota, and TexasFebruary 2025 arrest and detention of Ksenia Petrova, researcher at Harvard Medical School, for entering the country with undeclared frog embryos. (She was released in January 2026 and is back at work.)
7
Example 4: BoSS Program (BioStabilization Systems), Gloria ElliottAdditional Example?
8
NameE-mail AddressOrganizationYour Outlook Your Outlook
9
Importance in Your View3 - Moderately Important4 - Quite Important4 - Quite Important1 - Only Slightly Important4 - Quite Important4 - Quite Important4 - Quite Important4 - Quite Important4 - Quite Important
10
Comments
11
NameE-mail AddressOrganizationYour Outlook Your Outlook
12
Importance in Your View4 - Quite Important3 - Moderately Important3 - Moderately Important1 - Only Slightly Important4 - Quite Important
13
Comments
14
NameE-mail AddressOrganizationYour Outlook Your Outlook
15
Importance in Your View
16
Comments
17
NameE-mail AddressOrganizationYour Outlook Your Outlook
18
Importance in Your View
19
Comments
20
NameE-mail AddressOrganizationYour Outlook Your Outlook
21
Matt Handzelhandzelmatthew@gmail.comImportance in Your View3 - Moderately Important4 - Quite Important
22
Comments Right to try may be double edged sword; i.e. bryan johnson looking super young and fit because of xyz therapy (and more people like him) would be positive. i imagine there could be some potentially negative outcomes and people may point to this and say that is dangerous
23
NameE-mail AddressOrganizationYour Outlook Your Outlook
24
Importance in Your View
25
Comments
26
NameE-mail AddressOrganizationYour Outlook Your Outlook
27
Importance in Your View
28
Comments
29
NameE-mail AddressOrganizationYour Outlook Your Outlook
30
Importance in Your View
31
Comments
32
NameE-mail AddressOrganizationYour Outlook Your Outlook
33
Importance in Your View
34
Comments
35
NameE-mail AddressOrganizationYour Outlook Your Outlook
36
Importance in Your View
37
Comments
38
NameE-mail AddressOrganizationYour Outlook Your Outlook
39
Importance in Your View
40
Comments
41
NameE-mail AddressOrganizationYour Outlook Your Outlook
42
Importance in Your View
43
Comments
44
NameE-mail AddressOrganizationYour Outlook Your Outlook
45
Importance in Your View
46
Comments
47
NameE-mail AddressOrganizationYour Outlook Your Outlook
48
Importance in Your View
49
Comments
50
NameE-mail AddressOrganizationYour Outlook Your Outlook
51
Importance in Your View
52
Comments
53
NameE-mail AddressOrganizationYour Outlook Your Outlook
54
Importance in Your View
55
Comments
56
NameE-mail AddressOrganizationYour Outlook Your Outlook
57
Importance in Your View
58
Comments
59
NameE-mail AddressOrganizationYour Outlook Your Outlook
60
Importance in Your View
61
Comments
62
NameE-mail AddressOrganizationYour Outlook Your Outlook
63
Importance in Your View
64
Comments
65
NameE-mail AddressOrganizationYour Outlook Your Outlook
66
Importance in Your View
67
Comments
68
NameE-mail AddressOrganizationYour Outlook Your Outlook
69
Importance in Your View
70
Comments
71
NameE-mail AddressOrganizationYour Outlook Your Outlook
72
Importance in Your View
73
Comments
74
NameE-mail AddressOrganizationYour Outlook Your Outlook
75
Importance in Your View
76
Comments
77
NameE-mail AddressOrganizationYour Outlook Your Outlook
78
Importance in Your View
79
Comments
80
NameE-mail AddressOrganizationYour Outlook Your Outlook
81
Importance in Your View
82
Comments
83
NameE-mail AddressOrganizationYour Outlook Your Outlook
84
Importance in Your View
85
Comments
86
NameE-mail AddressOrganizationYour Outlook Your Outlook
87
Importance in Your View
88
Comments
89
NameE-mail AddressOrganizationYour Outlook Your Outlook
90
Importance in Your View
91
Comments
92
NameE-mail AddressOrganizationYour Outlook Your Outlook
93
Importance in Your View
94
Comments
95
NameE-mail AddressOrganizationYour Outlook Your Outlook
96
Importance in Your View
97
Comments
98
NameE-mail AddressOrganizationYour Outlook Your Outlook
99
Importance in Your View
100
Comments